Nov 3 (Reuters) – Botox maker Allergan Inc, which is fending off an acquisition by Valeant Pharmaceuticals Inc , said on Monday that it had been approached by another party regarding a potential transaction.
Source: Financials
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com